Next Article in Journal
Medullary Thyroid Cancer: An Introduction
Previous Article in Journal
Updates from the 2019 American Society of Clinical Oncology and European Hematology Association Annual Meetings: A Canadian Perspective on High-Risk Cytogenetics in Multiple Myeloma
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 26
Issue 4
10.3747/co.26.4779
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Letter

Reconsidering the Turnaround Times for BRAF V600 Mutation Analysis in Non-Small-Cell Lung Cancer: A Molecular Diagnosis in One Day Is Achievable for Rapid Treatment Choices

by
Arnaud Uguen
Department of Pathology, University Hospital Morvan, 2 avenue Foch, Brest 29609, France
Curr. Oncol. 2019, 26(4), 595-596; https://doi.org/10.3747/co.26.4779
Submission received: 2 May 2019 / Revised: 3 June 2019 / Accepted: 5 July 2019 / Published: 1 August 2019

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

As reported by Auliac et al., patients with BRAF-mutated non-small-cell lung cancer (NSCLC) have particular clinicopathologic features and prognosis. [...]

Share and Cite

MDPI and ACS Style

Uguen, A. Reconsidering the Turnaround Times for BRAF V600 Mutation Analysis in Non-Small-Cell Lung Cancer: A Molecular Diagnosis in One Day Is Achievable for Rapid Treatment Choices. Curr. Oncol. 2019, 26, 595-596. https://doi.org/10.3747/co.26.4779

AMA Style

Uguen A. Reconsidering the Turnaround Times for BRAF V600 Mutation Analysis in Non-Small-Cell Lung Cancer: A Molecular Diagnosis in One Day Is Achievable for Rapid Treatment Choices. Current Oncology. 2019; 26(4):595-596. https://doi.org/10.3747/co.26.4779

Chicago/Turabian Style

Uguen, Arnaud. 2019. "Reconsidering the Turnaround Times for BRAF V600 Mutation Analysis in Non-Small-Cell Lung Cancer: A Molecular Diagnosis in One Day Is Achievable for Rapid Treatment Choices" Current Oncology 26, no. 4: 595-596. https://doi.org/10.3747/co.26.4779

APA Style

Uguen, A. (2019). Reconsidering the Turnaround Times for BRAF V600 Mutation Analysis in Non-Small-Cell Lung Cancer: A Molecular Diagnosis in One Day Is Achievable for Rapid Treatment Choices. Current Oncology, 26(4), 595-596. https://doi.org/10.3747/co.26.4779

Article Metrics

Back to TopTop